Patents Assigned to Katairo GmbH
  • TETRAHYDROPYRIDOETHERS FOR TREATMENT OF AMD
    Publication number: 20220370425
    Abstract: A method is described in which treatment is carried out with compounds of tetrahydropyridoethers that are administered in form of a medication to treat AMD and to remove lipofuscin from a patient's eye.
    Type: Application
    Filed: July 14, 2022
    Publication date: November 24, 2022
    Applicants: Katairo GmbH, Takeda GmbH
    Inventors: Ulrich Schraermeyer, Jörg Senn-Bilfinger, Ernst Sturm
  • Methods for the determination of compounds or compositions for the treatment of lipofuscin related diseases and compounds or compositions
    Patent number: 10495630
    Abstract: A method for selecting a compound or a composition suitable for treating lipofuscin associated diseases in a patient, the method including the steps of determining a reactivity factor, determining a targeting factor that allows an uptake into a cell and a provides a targeting of lipofuscin, and selecting a compound or a composition or combining compounds to obtain a compound or composition that comprises a reactivity factor and an targeting factor.
    Type: Grant
    Filed: February 13, 2015
    Date of Patent: December 3, 2019
    Assignees: KATAIRO GMBH, TAKEDA GMBH
    Inventors: Ulrich Schraermeyer, Michael Burnet, Jörg Senn-Bilfinger, Ernst Sturm, Guido Hanauer
  • METHODS FOR THE DETERMINATION OF COMPOUNDS OR COMPOSITIONS FOR THE TREATMENT OF LIPOFUSCIN RELATED DISEASES AND COMPOUNDS OR COMPOSITIONS
    Publication number: 20170176416
    Abstract: A method for selecting a compound or a composition suitable for treating lipofuscin associated diseases in a patient, the method including the steps of determining a reactivity factor, determining a targeting factor that allows an uptake into a cell and a provides a targeting of lipofuscin, and selecting a compound or a composition or combining compounds to obtain a compound or composition that comprises a reactivity factor and an targeting factor.
    Type: Application
    Filed: February 13, 2015
    Publication date: June 22, 2017
    Applicant: KATAIRO GMBH
    Inventors: ULRICH SCHRAERMEYER, MICHAEL BURNET
  • TETRAHYDROPYRIDOETHERS FOR THE TREATMENT OF STARGARDT'S DISEASE
    Publication number: 20160235724
    Abstract: A pharmaceutical composition comprising tetrahydropyridoethers for use in the treatment of Stargardt's disease.
    Type: Application
    Filed: October 8, 2014
    Publication date: August 18, 2016
    Applicant: KATAIRO GMBH
    Inventor: ULRICH SCHRAERMEYER
  • Tetrahydropyridoethers for treatment of AMD
    Patent number: 9314453
    Abstract: A medication comprising tetrahydropyridoethers for use in the treatment of AMD.
    Type: Grant
    Filed: January 14, 2013
    Date of Patent: April 19, 2016
    Assignee: Katairo GmbH
    Inventor: Ulrich Schraermeyer